Home Healthcare Biotechnology Procalcitonin Market

Procalcitonin Market Size, Share & Trends Analysis Report By Product Type (Procalcitonin Antigen, Procalcitonin Antibody), By Technology (Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Fluorescent Assay (ELFA), Others), By Applications (Medical, Scientific Research, Others), By End-User (Hospitals, Diagnostic Laboratories, Point-of-Care Testing (POCT), Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR414DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Procalcitonin Market, By Product Type 2022-2034 (USD MILLION/ Units)
    1. Procalcitonin Antigen
    2. Procalcitonin Antibody
  2. Procalcitonin Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Chemiluminescence Immunoassay (CLIA)
    2. Enzyme-Linked Fluorescent Assay (ELFA)
    3. Others
  3. Procalcitonin Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Medical
    2. Scientific Research
    3. Others
  4. Procalcitonin Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Diagnostic Laboratories
    3. Point-of-Care Testing (POCT)
    4. Others
  5. Regional Procalcitonin Market
    1. North America
      1. North America Procalcitonin Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
      2. North America Procalcitonin Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Chemiluminescence Immunoassay (CLIA)
        2. Enzyme-Linked Fluorescent Assay (ELFA)
        3. Others
      3. North America Procalcitonin Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Medical
        2. Scientific Research
        3. Others
      4. North America Procalcitonin Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Point-of-Care Testing (POCT)
        4. Others
      5. U.S.
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      6. Canada
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
    2. Europe
      1. Europe Procalcitonin Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
      2. Europe Procalcitonin Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Chemiluminescence Immunoassay (CLIA)
        2. Enzyme-Linked Fluorescent Assay (ELFA)
        3. Others
      3. Europe Procalcitonin Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Medical
        2. Scientific Research
        3. Others
      4. Europe Procalcitonin Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Point-of-Care Testing (POCT)
        4. Others
      5. U.K.
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      6. Germany
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      7. France
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      8. Spain
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      9. Italy
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      10. Russia
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      11. Nordic
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      12. Benelux
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      13. Rest of Europe
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
    3. APAC
      1. APAC Procalcitonin Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
      2. APAC Procalcitonin Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Chemiluminescence Immunoassay (CLIA)
        2. Enzyme-Linked Fluorescent Assay (ELFA)
        3. Others
      3. APAC Procalcitonin Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Medical
        2. Scientific Research
        3. Others
      4. APAC Procalcitonin Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Point-of-Care Testing (POCT)
        4. Others
      5. China
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      6. Korea
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      7. Japan
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      8. India
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      9. Australia
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      10. Singapore
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      11. Taiwan
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      12. South East Asia
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      13. Rest of Asia-Pacific
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
    4. Middle East and Africa
      1. Middle East and Africa Procalcitonin Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
      2. Middle East and Africa Procalcitonin Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Chemiluminescence Immunoassay (CLIA)
        2. Enzyme-Linked Fluorescent Assay (ELFA)
        3. Others
      3. Middle East and Africa Procalcitonin Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Medical
        2. Scientific Research
        3. Others
      4. Middle East and Africa Procalcitonin Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Point-of-Care Testing (POCT)
        4. Others
      5. UAE
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      6. Turkey
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      7. Saudi Arabia
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      8. South Africa
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      9. Egypt
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      10. Nigeria
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      11. Rest of MEA
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
    5. LATAM
      1. LATAM Procalcitonin Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
      2. LATAM Procalcitonin Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Chemiluminescence Immunoassay (CLIA)
        2. Enzyme-Linked Fluorescent Assay (ELFA)
        3. Others
      3. LATAM Procalcitonin Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Medical
        2. Scientific Research
        3. Others
      4. LATAM Procalcitonin Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Point-of-Care Testing (POCT)
        4. Others
      5. Brazil
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      6. Mexico
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      7. Argentina
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      8. Chile
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      9. Colombia
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
      10. Rest of LATAM
        1. Procalcitonin Antigen
        2. Procalcitonin Antibody
        3. Chemiluminescence Immunoassay (CLIA)
        4. Enzyme-Linked Fluorescent Assay (ELFA)
        5. Others
        6. Medical
        7. Scientific Research
        8. Others
        9. Hospitals
        10. Diagnostic Laboratories
        11. Point-of-Care Testing (POCT)
        12. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.